CBD effective against drug-resistant bacteria [VIDEO].

Not helped by antibiotics or any other medication, CBD cannabidiol can help. According to recent scientific studies, the organic compound found in the hemp plant can effectively fight staphylococcus aureus, as well as wounds and ulcers caused by diabetes. However, it doesn't stop there...

The compound in cannabis also kills the bacteria that cause gonorrhea, meningitis and legionellosis. This is the result of a joint discovery by the Intitute of Molecular Biosciences (IMB) at Australia's Queensland State University and pharmaceutical company Botanix Pharmaceuticals Ltd.

Such groundbreaking research results could eventually lead to the creation of the first group of antibiotics in 60 years to effectively combat previously drug-resistant bacteria.

Staphylococcus, gonorrhea and ulcers...

The findings of the Australian researchers were published in the journal Communications Biology. For the first time in the history of medicine, it was seen that CBD kills Gram-negative bacteria such as gonorrhea (Neisseria gonorrhoeae).

- These bacteria have an additional line of defense against antibiotics in the form of an outer membrane that cannot be penetrated. CBD pierces it," explained Dr. Mark Blaskovich, head of the IMB.

Effectively fighting gonorrhea is a priority in Australia, as it is the country's second most commonly sexually transmitted disease. As a result, doctors do not have one fully effective antibiotic to combat it.

CBD is also proving effective in treating staphylococcus aureus and ulcers caused by diabetes. - CBD has shown a low tendency to produce drug resistance even when administered in increased concentrations, Dr. Blaskovich added.

CBD-based antibiotics

Scientific studies conducted confirm that CBD cannabidiol penetrates and bursts the outer shell of drug-resistant bacteria. Pharmaceutical conglomerate Botanix has announced the creation of a new synthetic variety of CBD that does not break down as quickly as the one currently available.

And this means the announcement of the creation of a new variety of antibiotics that will be effective against drug-resistant bacteria.

Source: https://www.national-geographic.pl/